• / Free eNewsletters & Magazine
  • / My Account

Related Content

  1. Videos
  2. Articles
  1. Experts Answer Your Retirement Questions

    Financial planner Mark Balasa and Morningstar's Christine Benz and David Blanchett tackled viewers' most pressing retirement questions, from determining savings rates and income needs to planning for Social Security and maximizing retirement accounts.

  2. Fund Favorites and Follies Over 20 Years

    In this special 50-minute panel discussion, Morningstar's Christine Benz, Russ Kinnel, and John Rekenthaler chart fund investing's course over the last two decades, discuss investors' biggest challenges today, and reveal some of their favorite longtime picks.

  3. Ready Your Portfolio for Retirement

    Morningstar's Christine Benz demonstrates how to make a bucket portfolio best work for you, touching on allocation, RMDs, other income sources, and more.

  4. Become a Better Index Investor

    Roundtable Report: Experts dig into the ETF versus index fund debate, active and passive strategies, fixed-income benchmarks, factor investing, and much more.

Stock Is Dead?

Bill Gross says the 'cult of equity is dying.' Is he right?

Shannon Zimmerman, 09/06/2012

Bill Gross' name may be synonymous with bond investing, but PIMCO's co-founder and CIO isn’t shy about weighing in on equities. During the keynote address that kicked off the 2011 Morningstar Investment Conference, Gross suggested that, with interest rates at anemic levels and with inflation essentially having nowhere to go but up, income-seekers should favor high-quality dividend-paying stocks over most flavors of fixed income. Gross mentioned energy concern Southern Company SO as one contender for investment dollars that might otherwise flow to fixed income. He also gave Johnson & Johnson JNJ a buy rating in his guise as an equity analyst.

Some in the audience seemed surprised by Gross’ equity-centric comments, but that probably owed to his candor about the prospects for bonds. When the manager of  PIMCO Total Return PTTRX--with assets in excess of a quarter trillion dollars--touts stocks over bonds, that's newsworthy even if the suggestion he made seemed merely sensible at the time.

This Year's Model
It seems sensible now, too. Yes, even the sturdiest of stocks will subject investors to more volatility than will investment-grade bonds. Yields on five -, seven-, and 10-year Treasuries are currently negative in real (inflation-adjusted) terms, though, and the 30-year Treasury bond pays a whopping 0.50%. Yields on corporate bonds are also paltry. The iShares iBoxx $ Invest Grade Corporate Bond LQD exchange-traded fund currently pays around 4%, but that’s in nominal, not real, terms. Those inclined to stretch for yield by stepping down the credit-quality ladder and into a high-yield vehicle such as SPDR Barclays Capital High Yield Bond JNK ETF will be rewarded for their effort with a nominal payout of around 7%. That's a tidy sum relative to what's on offer in other areas of the bond market. Yet given the asset class' historically high risk, many prospective high-yield investors may wonder if, on an absolute basis, 7% is sufficient reward for the risk that comes with investing in junk bonds.

Topnotch actively managed mutual funds in Morningstar's intermediate-term bond category aren’t faring any better in terms of yield, either. Dodge & Cox Income DODIX sports a Morningstar Analyst Rating of Gold and a barely there nominal payout of 2.5%. Fidelity Total Bond FTBFX and Gross’ own PIMCO Total Return have also earned Gold analyst ratings. Currently, those long-term keepers nominally yield 3.3% and 3.8%, respectively.

Long Live Stock
It’s a different story among equities, dividend-payers included. Despite a rally among income-producing stocks so strong that some are using the B word to describe it, disappointed fixed-income fans can still find compelling opportunities with attractive risk/reward profiles.

Johnson & Johnson, for example, currently yields roughly 3.5%, and trades in line with most of its historical price multiples. Daimler AG DDAIF, Sanofi ADR SNY, and Novartis AG NVS all pay out in excess of 4%. Yes, those are nominal figures. The share prices of those companies imply upside potential, though, with each firm trading at a double-digit discount to the fair value estimates of Morningstar equity research.

Yet even though the advice Gross gave in 2011 still seems sound, he’s no longer offering it. With his characteristic gift for overstatement (and a newfound knack for Romantic poetry), Gross declares flatly in his most recent Investment Outlook, "The cult of equity is dying. Like a once bright green aspen turning to subtle shades of yellow then red in the Colorado fall, investors' impressions of 'stocks for the long run' or any run have mellowed as well."

Gross doesn’t have particularly high hopes for bonds, either. In his view, the prognosis for long-term Treasuries especially is, sticking with his metaphor, even more morbid.

Shannon Zimmerman is an associate director of fund analysis at Morningstar.
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.